Aurora Cannabis Inc. (TSE:ACB) shares have retraced a considerable 28% in the last month, reversing a fair amount of their solid recent performance. Instead of being rewarded, shareholders who have already held through the last twelve months are now sitting on a 12% share price drop.
In spite of the heavy fall in price, you could still be forgiven for feeling indifferent about Aurora Cannabis’ P/S ratio of 1x, since the median price-to-sales (or “P/S”) ratio for the Pharmaceuticals industry in Canada is also close to 0.9x. While this might not raise any eyebrows, if the P/S ratio is not justified investors could be missing out on a potential opportunity or ignoring looming disappointment.
Check out our latest analysis for Aurora Cannabis
